Document Detail


Synergistic effects on pregnancy-termination activity of DL111-IT in combination with mifepristone.
MedLine Citation:
PMID:  9812725     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To clarify the role of DL111-IT when combined with mifepristone (Mif) on termination of early pregnancy. METHODS: Progesterone receptors (PR) was measured using radioligand assay (RA), and peroxidase-antiperoxidase (PAP) immuno-histochemistry. Decidual cells (DC) were estimated using cell culture and histological examination (HE) (including fetus). RESULTS: DL111-IT 100 mg.kg-1 i.m., Mif 5 mg.kg-1 i.g., DL111-IT 16 mg.kg-1 i.m. + Mif 1.5 mg.kg-1 i.g. and tea seed oil (TSO) 2 mL.kg-1 i.m. on d 7 of pregnancy in rats, DC and fetus of treated groups were found to be degenerated at 24 h after treatment, at 48 h after treatment, PAP labeling index (%) of uterus PR of 4 groups were 22 +/- 4, 18.7 +/- 2.9, 10.3 +/- 1.2, 52 +/- 15, respectively. Rats i.m. DL111-IT 100 mg.kg-1 24 h after treatment, the quantity of PR decreased by 47% vs that of TSO. The affinity of PR with Mif and progesterone did not change. Cultured human DC were exposed to DL111-IT and Mif 0-50 mg.L-1, alone or combinatively, for 24 h. LD50 (mg.L-1) were: DL111-IT 18.1 (15.1-21.4), Mif 25.0 (23.1-26.9), DL111-IT 5.0 plus Mif 3.5 (1.8-6.5) or Mif 5.0 plus DL111-IT 4.6 (1.1-7.3), respectively. CONCLUSION: DL111-IT enhanced action of Mif on DC, reduced quantity of PR, so the 2 drugs had the synergistic action in termination of early pregnancy.
Authors:
B Yang; R Y Fang
Related Documents :
12410365 - Sex hormones, hemostasis and early pregnancy loss.
16253385 - Neural steroid hormone receptor gene expression in pregnant rats.
21290395 - Umbilical cord insertion into the lower segment of the uterus at 11 to 13 weeks' gestat...
21326865 - A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chor...
16360495 - Addressing the growing problem of multiple gestations created by assisted reproductive ...
3046795 - Abnormal antepartum fetal heart rate patterns and subsequent handicap.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Zhongguo yao li xue bao = Acta pharmacologica Sinica     Volume:  17     ISSN:  0253-9756     ISO Abbreviation:  Zhongguo Yao Li Xue Bao     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1999-02-16     Completed Date:  1999-02-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8100330     Medline TA:  Zhongguo Yao Li Xue Bao     Country:  CHINA    
Other Details:
Languages:  eng     Pagination:  361-5     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, School of Pharmacy, Zhejiang Medical University, Hangzhou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / pharmacology
Abortifacient Agents, Steroidal / pharmacology
Abortion, Induced*
Animals
Cells, Cultured
Decidua / cytology,  drug effects
Drug Synergism
Female
Humans
Mifepristone / pharmacology*
Pregnancy
Rats
Rats, Sprague-Dawley
Receptors, Progesterone / metabolism
Triazoles / pharmacology*
Uterus / metabolism
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Abortifacient Agents, Steroidal; 0/Receptors, Progesterone; 0/Triazoles; 69095-83-6/3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intracellular Ca2+ during fertilization and artificial activation in mouse oocytes.
Next Document:  SK&F 105494, a V2-vasopressin receptor antagonist, blocks oxytocin receptors in porcine myometrium.